Aug 09, 2024 / 01:00AM GMT
Gerry Zhao - Neuren Pharmaceuticals Ltd - Vice President - Corporate Development
Hi. Good morning, all. Welcome to Neuren's investor webinar to discuss Phase II results for Angelman syndrome. My name is Gerry Zhao, Vice President of Corporate Development at Neuren. Joining me on the call today from Neuren are Jon Pilcher, CEO; and Liza Squires, Chief Medical Officer.
John and Liza will make the presentation today and all of us will be available for Q&A session following the presentation. (Event Instructions)
Before we start, I would like to remind everyone that we will be making forward-looking statements during today's call, which are subject to risks and uncertainties that may lead to different outcomes. I'll now turn the call over to Jon to start the presentation.
Jon Pilcher - Neuren Pharmaceuticals Ltd - Chief Executive Officer, Managing Director, Executive Director
Thanks so much, Gerry. Good morning, everyone. Thanks very much for joining us. I know it's a busy time and reporting season. So I appreciate your time, and we'll try and
Neuren Pharmaceuticals Ltd Investor Webinar Transcript
Aug 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers